Women, Black and Hispanic Adults Have Lower Angiography/PCI Use in NSTEMI
By Elana Gotkine HealthDay Reporter
THURSDAY, May 16, 2024 -- Disparities are evident in the interventional management of non-ST-segment elevated myocardial infarction (NSTEMI) and in STEMI incidence and mortality, according to two studies presented at the annual meeting of the Society for Cardiovascular Angiography and Interventions, held from May 2 to 4 in Long Beach, California.
Mandvi Pandey, M.D., from Texas Health Resources in Bedford, and colleagues conducted a retrospective analysis of National Inpatient Sample data from 2016 to 2020 for adults with type 1 NSTEMI. Participants underwent coronary angiography (CA) or percutaneous coronary intervention (PCI) for NSTEMI; gender and racial disparities were examined in interventional management for 2,153,124 NSTEMI patients. The researchers found that compared with men, women had significantly lower adjusted odds of undergoing CA/PCI (adjusted odds ratio [aOR], 0.816); lower adjusted odds of undergoing CA/PCI were also seen for Black and Hispanic versus White patients (aORs, 0.746 and 0.831, respectively).
Fares Ghanem, M.D., from Southern Illinois University in Springfield, and colleagues examined demographic trends in U.S. STEMI hospitalizations using data from 3,426,898 eligible patients. The researchers found that from 2004 to 2020, there was a steady decrease in overall STEMI incidence from 98.7 to 49 per 100,000 inpatient hospitalizations per population, especially among older individuals. In small and medium-sized hospitals, STEMI incidence increased, while in large hospitals, it decreased. In the lower-income population, STEMI incidence and mortality were higher. Mortality declined for individuals older than 85 years and those aged 65 to 84 years, while a slight increase was seen for those aged 45 to 65 years.
"The disparities uncovered by our study emphasize there is a gap in care," Ghanem said in a statement. "We encourage clinicians to focus on providing equitable access to high-quality care through increased education and implementing targeted interventions for vulnerable populations."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
ACC: Empagliflozin Does Not Cut Risk for Heart Failure After Acute MI
WEDNESDAY, April 10, 2024 -- Empagliflozin does not reduce the risk for first hospitalization for heart failure or death among patients at increased risk for heart failure after...
ACC: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI
MONDAY, April 8, 2024 -- For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a...
Risk for MI, Stroke, Death Increased With Plastics in Carotid Plaques
FRIDAY, March 8, 2024 -- Patients in whom microplastics and nanoplastics (MNPs) are detected within carotid plaques have an increased risk for a composite end point of myocardial...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.